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Oropouche  virus,  of  the family  Bunyaviridae,  genus  Orthobunyavirus,  serogroup  Simbu, is  an  important
causative  agent  of  arboviral  febrile  illness  in Brazil.  An  estimated  500,000  cases  of Oropouche  fever
have  occurred  in  Brazil  in  the  last  30  years,  with  recorded  cases  also  in  Panama,  Peru,  Suriname  and
Trinidad.  We  have  developed  an  experimental  model  of Oropouche  virus  infection  in  neonatal  BALB/c
mouse  by subcutaneous  inoculation.  The vast  majority  of infected  animals  developed  disease  on  the  5th
day  post  infection,  characterized  mainly  by lethargy  and  paralysis,  progressing  to  death  within  10  days.
Viral  replication  was  documented  in  brain  cells by  in  situ  hybridization,  immunohistochemistry  and  virusunyaviridae
athogenesis
eurotropism
titration.  Multi-step  immunohistochemistry  indicated  neurons  as  the  main  target  cells  of OROV  infection.
Histopathology  revealed  glial  reaction  and  astrocyte  activation  in  the brain  and spinal  cord,  with  neuronal
apoptosis.  Spleen  hyperplasia  and mild  meningitis  were  also  found,  without  viable  virus  detected  in liver
and  spleen.  This  is  the  ﬁrst  report  of an  experimental  mouse  model  of OROV  infection,  with  severe
involvement  of the  central  nervous  system,  and  should  become  useful  in  pathogenesis  studies,  as  well as
in  preclinical  testing  of  therapeutic  interventions  for this  emerging  pathogen.. Introduction
Oropouche virus (OROV), a member of the family Bunyaviri-
ae, genus Orthobunyavirus, serogroup Simbu, is the second most
requent cause of arboviral febrile illness in Brazil. An estimated
00,000 cases of Oropouche fever have occurred in Brazil in the
ast 30 years, with recorded cases also in Panama, Peru, Suriname
nd Trinidad (Pinheiro et al., 1997). OROV may  emerge in other
reas of the Americas due to deforestation, global warming and
edistribution of insect vectors and reservoirs. OROV infection is
haracterized by fever and other systemic symptoms, with or with-
ut rash and conjunctival congestion, lasting for 2–5 days, although
he malaise may  last for up to one month. Despite the fact that OROV
nfections can cause severe impairment in acutely ill patients, there
as been no record of OROV-attributable mortality (Pinheiro et al.,
997, 1981).Suckling mice and hamsters are susceptible to OROV infection
y intracerebral inoculation (Araujo et al., 1978; Pinheiro et al.,
976; Watts et al., 1997), a route that has been used mainly for
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crude antigen preparation and recovery of OROV from ﬁeld sam-
ples. Experimental inoculation of hamsters with OROV by the
subcutaneous route, which more closely resembles the natural
route of infection, induces systemic infection with strong tropism
for liver and brain, causing severe symptoms, including paraly-
sis and death (Rodrigues et al., 2011). However, hamsters are not
isogenic animals for which speciﬁc reagents are hardly available,
making this model unsuitable for detailed immunological studies
on virus–host interactions. Therefore, an experimental model of
OROV infection of isogenic mouse is needed. This report describes
a mouse model of OROV infection, which should become use-
ful in studies of pathogenesis and to test antiviral compounds
and vaccines. In this model, OROV induced paralytic disease
with remarkable involvement of neurons of the central nervous
system.
2. Materials and methods
2.1.  Virus
Open access under the Elsevier OA license.OROV (strain BeAn 19991) was kindly provided by Luiz Tadeu
Moraes Figueiredo (University of São Paulo School of Medicine,
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assages in Swiss suckling mouse brain, followed by one passage
n HeLa cells. The stock was cleared by centrifugation at 5000 × g,
ltered through a 0.22 m membrane and titrated by detection
f cytopathic effect (CPE) in serial 10-fold dilutions inoculated in
uadruplicates of Vero cell cultures. The ﬁnal titer of OROV was
btained was 107.25 TCID50/mL.
.2. Animals
One day old BALB/c mice obtained from the Central Animal Facil-
ty of the University of São Paulo, School of Medicine, in Ribeirão
reto, SP, Brazil were kept in accordance with guidelines of the
niversity of São Paulo Committee on Care and Use of Laboratory
nimals (protocol #165/2008).
.3. Inoculation, tissue harvesting and virus titration
Twenty mice were inoculated subcutaneously on the dorso-
umbar area with 106.25 TCID50 of OROV and examined twice
aily for clinical abnormalities. Animals to be euthanized for tis-
ue harvesting were anesthetized with a mixture of ketamine
80 mg/kg) and xylazine (15 mg/kg), and then exsanguinated by
erfusion with PBS, pH 7.4. Brain, liver, spleen, heart, thymus and
ancreas were obtained by dissection under aseptic conditions,
eighed and manually homogeneized by grinding in 1 mL of MEM
ith 2% heat-inactivated fetal bovine serum (FBS), and stored at
70 ◦C for later virus titration. For titrations, samples were thawed,
leared by centrifugation at 5000 × g at 4 ◦C for 10 min  and ﬁl-
ered through 0.22 m syringe-mounted ﬁlters. Virus titres were
alculated by inoculating 10-fold serial dilutions of plasma or tis-
ue homogenates in quadruplicate monolayers of Vero cells grown
n 96-well plates (Reed and Muench, 1938). The presence of cyto-
athic effect (CPE) was evaluated on the third day of incubation at
7 ◦C in 5% CO2, and expressed in TCID50 per gram of tissue. The cells
t the end-point of CPE readings and those at wells inoculated with
ne further serial dilution were scraped off, placed on slides, ﬁxed
ith acetone and tested by immunoﬂuorescence (IF) with anti-
ROV polyclonal mouse antiserum (kindly provided by Luiz Tadeu
oraes Figueiredo, University of São Paulo School of Medicine,
ibeirão Preto, SP, Brazil) diluted 1:100 in PBS pH 7.4 (Invitrogen
 Gibco, Grand Island, NY). The slides were then washed in PBS for
 min  and incubated with FITC-labeled goat anti-mouse antibody
Chemicon, Carpinteria, CA) diluted 1:50 in PBS with 1:20 Evans
lue. Another set of animals were euthanized in the same way,
erfused with PBS and then with buffered formaldehyde (pH 7.4).
heir tissues were postﬁxed in 3.7% neutral buffered formaldehyde
or 24 h, dehydrated in increasing ethanol concentration, treated in
ylenes and parafﬁn-embedded (Luna, 1968).
.4. Immunoﬂuorescence and TUNEL assay
Six m frozen sections were prepared with OROV-infected brain
n accordance with standard protocols. Sections were ﬁxed with 2%
araformaldehyde in PBS, blocked with 7 g/mL donkey IgG in PBS
upplemented with 1% bovine serum albumine, pH 7.4 (PBS–BSA –
nvitrogen). Mouse monoclonal antibodies (MAb) against neuron-
peciﬁc nuclear protein (Mullen et al., 1992) (NeuN – Millipore) or
lial ﬁbrillary acidic protein (Valentino et al., 1983) (GFAP – Milli-
ore) were incubated for 1 h at room temperature. After extensive
ashes, slides were incubated with donkey anti-mouse conjugated
ith Alexaﬂuor 488 (Invitrogen) for 1 h at room temperature. Tis-
ue sections were washed 4 times with PBS and then subject to
UNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick
nd-labeling) assay for apoptosis, using TUNEL in situ Cell Death
etection Kit, TMR  red (Roche, Basel, Switzerland). Tissue sections
ere incubated with the deoxynucleotidyltransferase (tdt) mix  forrch 170 (2012) 25– 33
1 h at 37 ◦C, followed by extensive washes and mounting with
Fluoromount (EM Science). TUNEL assay was performed on the
same slides after stained by IF to identify apoptotic cells. Confo-
cal optical sections were collected using Leica TCS-SP2 SE confocal
system.
2.5. Histology and immunohistochemistry
For histopathology, 5 m tissue sections were stained with
hematoxylin–eosin (HE) following routine protocols (Luna, 1968).
Tissue sections were deparafﬁnized in xylenes, re-hydrated in
decreasing concentrations of ethanol, and then treated for antigen
unmasking in boiling citrate buffer (pH 6.0) followed by incuba-
tion with 4% H2O2 for 30 min. For OROV antigen detection, sections
were washed in PBS and incubated for 20 min in PBS–BSA with
3% goat serum and then for 1 h with anti-OROV rabbit polyclonal
antibody (rabbit immune serum against recombinant OROV pro-
tein N) diluted 1:300 in PBS–BSA and 0.1% Triton X-100 (Sigma)
pH 7.4 at room temperature. Slides were incubated with 1:2000
biotinylated goat anti-rabbit immunoglobulin (Dako) in PBS pH
7.4 for 30 min  at room temperature (Ausubel, 2003). Detection
of biotinylated antibody was  done with Streptavidin-peroxidase
Ultrasensitive Polimer (Sigma) (Graf and Friedl, 1999) followed
by either diaminobenzidine or 3-amino-9-ethylcarbazole (Sigma).
Slides were counterstained with Harris hematoxylin and mounted
with Permount (Fisher) (Ausubel, 2003). For NeuN detection, sam-
ples were incubated with PBS–BSA containing 3% horse serum, and
then with 1:100 mouse MAb  anti-NeuN (Millipore) in PBS–BSA
with 0,1% Triton X-100 (Sigma), followed by 1:100 goat anti-mouse
conjugated with horseradish peroxidase (Zymed) in PBS–BSA for
30 min. Peroxidase substrate and counterstaining protocols were
the same used for OROV detection. For GFAP detection, sections
were incubated for 20 min  in PBS–BSA supplemented with 7 g/mL
donkey IgG and then for 1 h with 1:300 chicken IgY anti-GFAP
(Millipore) in PBS–BSA with 0.1% of Triton X-100 at room tem-
perature. The slides were then incubated with 1:1000 biotinylated
donkey anti-IgY (Invitrogen) in PBS for 30 min  at room temperature.
Detection of biotinylated antibody and all subsequent procedures
were the same used for OROV detection. For the detection of ion-
ized calcium-binding adaptor molecule 1 (Iba-1), sections were
washed in PBS and incubated for 20 min  in PBS–BSA with 3% horse
serum and then for 1 h with 1:50 goat anti-Iba-1 (Postler et al.,
2000) polyclonal antibody (Abcam) in PBS–BSA with 0.1% of Tri-
ton X-100 at room temperature. The slides were then incubated
with 1:100 rabbit anti-goat immunoglobulin (Zymed) conjugated
with HRP in PBS for 30 min at room temperature. Peroxidase sub-
strate and couterstaining protocols were the same used for OROV
detection.
Antibody to OROV recombinant N protein was obtained by
standard protocols. Brieﬂy, N protein was expressed using The
QIAexpressionistTM kit (Qiagen, Valencia, CA, USA) with the
plasmid PQe-30, transfected in Escherichia coli M15, following man-
ufacturer’s instructions. The vector containing OROV recombinant
N protein was a gift from Dr. Victor Hugo Aquino (Pharmaceutical
Sciences School, University of Sao Paulo, Ribeirao Preto). Recombi-
nant OROV N protein was inoculated intramuscularly in a female
rabbit (200 g/dose) mixed with complete Freund‘s adjuvant fol-
lowed by two additional doses with incomplete Freund’s adjuvant.
After 15 days of the last dose, animal serum was collected and the
presence of anti-N antibody was  conﬁrmed by immunoblot.
2.6. In situ hybridization (ISH)Tissue sections were deparafﬁnized in xylenes, re-hydrated
in decreasing concentrations of ethanol and the ISH procedure
was performed in RNase-free conditions following published


























cig. 1. Clinical data and virus titres in BALB/c neonate mice infected with OROV. (A
irus  titers in the brains of animals in three independent experiments (black arrow
nimal with hind limb paralysis.
rotocol (Ausubel, 2003). Brieﬂy, 5′biotinylated oligonucleotide
robes directed to OROV small (S) and medium (M)  positive-
tranded RNAs were diluted in SSC (sodium chloride 0.15 M/sodium
itrate 0.015 M)  supplemented with 2 mg/mL BSA and 8% dex-
ran sulfate and incubated on tissue sections for 4 h at 37 ◦C. After
equential washes in 1×, 2× and 4× SSC, slides were treated with
he Tyramide ampliﬁcation system (“DakoCytomationGenPoint”
 DakoCitomationInc, Carpinteria, CA, USA), following manufac-
urer’s instructions (Bobrow et al., 1991). The oligonucleotide
robe sequences were 5′TTGCGTCACCATCATTCCAA3′ for the S
nd 5′GACCACAATTTACGGTTACATGCT3′ for the M viral RNA seg-
ents, both including one biotin moiety at the 5′end during
ynthesis.
.7. Same-section staining by sequential immunohistochemistry
Immunohistochemistry was performed as described above and
lides were mounted with buffered glycerol for image acquisition.
overslips were immediately removed by immersion in water and
issue sections were dehydrated in increasing concentrations of
thanol. Slides were incubated in ethanol until no trace of alcohol-
oluble AEC peroxidase substrate was visible by checking under the
icroscope (Alkaissi and Mostratos, 1983). Sequential immunohis-
ochemical reactions were performed on the same tissue sections
sing primary antibodies from four different animal species, thus
ircumventing the need for antibody stripping before incubationtality curve; (B) weight gain of control (N = 5) and OROV-infected mice (N = 6); (C)
ates symptoms onset); (D) control (white arrow) and infected (white arrowhead)
with the respective secondary antibodies. Sequential stainings
were done with anti-OROV N protein rabbit polyclonal antibody,
anti-NeuN mouse monoclonal antibody, anti-GFAP chicken anti-
body and anti-iba-1 goat antibody were executed as previously
described in immunohistochemistry section. After each round of
immunohistochemical staining, horseradish peroxidase was com-
pletely blocked with 3% H2O2 (Dolman et al., 1975; Weinryb, 1966).
Blocking of nonspeciﬁc binding of secondary antibody was done
prior to the ﬁrst round of immunohistochemistry, with 7 g/mL
donkey IgG in PBS–BSA and 0.1% Triton X-100. Tissue sections were
counterstained with hematoxylin after each round of immunohis-
tochemistry.
3. Results
3.1. Clinical observations and virus titres
Of 20 newborn animals inoculated with 106.25 TCID50 of OROV,
none developed observable clinical symptoms until the 5th day
post inoculation (p.i.), when suddenly 10 (50%) of them died, and 7
others (35%) became sick, 4 of them severely, with weight loss, apa-
thy and paralysis, and died in the following two days. The remaining
3 (15%) animals did not develop disease all through the experiment.
Therefore, OROV lethality rate was 85% in this group of animals
(Fig. 1A).























(ig. 2. Histopathological ﬁndings (HE staining). (A) Control brain; (B) brain of OR
f  OROV-infected animal without microglial activation; (E) normal spleen; (F) sp
E  and F).
.2. The disease caused by OROV in the animals was
haracterized by a halt in body growth
(Fig. 1B), shiver, apathy and, at the ﬁnal stages, immobility and
omplete inability to suckle. A lethargic posture in lateral decubitus
as consistently present in sick animals, with frequent hind limb
aralysis (Fig. 1D).
OROV was recovered in cell culture from brain homogenates
rom all sick animals, but not from other organs. Virus titers reached
03–104 TCID50/g of tissue around 120 h p.i. (Fig. 1C).
.3. Histological and immunohistochemical ﬁndings
The CNS was the site of OROV infection in this model. On HE-
tained sections, the brain remained normal up to the 3rd day p.i.,
hen 3 of 7 animals developed mild lymphocytic meningitis, which
ecame apparent in all animals on the 5th day. Microglia activa-
ion, the only histopathological alteration seen in the brain cortex
Fig. 2B), was not observed in the spinal cord (Fig. 2D).
In spite of the mild histopathological ﬁndings, immunostain-
ng for the OROV nucleocapsid protein revealed abundant signal in
rain and spinal cord (Fig. 3B and D). ISH with probes speciﬁc for
ROV positive-stranded RNA revealed that an abundant number
f brain cells are sites of replication (Fig. 3F). Strong immunostain-
ng for GFAP, indicative of activated astrocytes, was also diffusely
ound in brain and spinal cord, suggesting extensive reactive gliosis
Fig. 4B and D). In addition, diffusely scattered Iba1-positive cellsfected animal with microglial activation; (C) control spinal cord; (D) spinal cord
f OROV-infected animal with hyperplasia. Magniﬁcations: 400× (A–D) and 100×
were found throughout the brain (Fig. 4F) and spinal cord (Fig. 4H)
of OROV-infected mice, in signiﬁcant contrast with the virtual lack
of Iba-1 signal found in mock-infected animals. In infected animals,
staining for this Ca2+-binding peptide marker of activated mono-
cytes and microglial cells (Postler et al., 2000) was  frequently found
in association with features reminiscent of neural phagocytosis
(Fig. 4F).
Splenic hyperplasia was  observed in all infected animals
(Fig. 2F). Pancreas, skin, heart, skeletal muscle and thymus
remained undistinguishable from the controls (data not shown).
The presence of a few giant cells was the only abnormality noted
in the liver of infected animals (data not shown).
3.4. Apoptosis
The paucity of inﬂammation in the brain suggests that the neu-
ronal damage in OROV infected animals may  result from apoptosis,
rather than necrosis, and this, coupled with apoptosis induction by
OROV in vitro (Clarke et al., 2005; Majno and Joris, 1995), prompted
us to test brain frozen sections for the presence of DNA fragmenta-
tion. DNA fragmentation upon infection in brain sections by TUNEL
was clearly increased (Fig. 5A) on day 3 p.i. and thereafter. Brain sec-
tions were double-labeled for DNA fragmentation and either NeuN
or GFAP, and then examined by confocal microscopy. The frequent
colocalization of apoptosis with the labeling for NeuN, but not for
GFAP, suggests that OROV induced apoptosis of neurons in the
R.I. Santos et al. / Virus Research 170 (2012) 25– 33 29
Fig. 3. OROV in mouse brain and spinal cord on the 6th day post inoculation. A through D: immunohistochemistry with anti-OROV N protein rabbit serum; E and F: ISH for





















2ROV  positive-strand RNA. Positivity is indicated by brown staining in both assays
pinal  cord of mock-infected animal; (D) spinal cord of OROV-infected animal. Mag
rain of experimentally infected mice (Mullen et al., 1992) (Fig. 5B
nd C).
.5. Sequential immunohistochemical staining of brain
The identity of OROV-infected cells in the brain was  further ana-
yzed by immunostaining of the same tissue sections sequentially
abeled for OROV, NeuN, GFAP and Iba1. Most of the OROV-positive
ells were positive for NeuN, while there was virtually no coin-
idence of positive labeling for OROV with GFAP staining (Fig. 6).
his result indicates that replication of OROV in the brain of exper-
mentally infected mouse is associated with neurons. In addition,
ba1-positivity was noted on a few scattered cells, frequently in
lose proximity to remains of OROV-positive neurons (Fig. 6), prob-
bly an indication of neuronal phagocytosis by microglia.
. Discussion
In this study the experimental infection of suckling mice by
ROV caused abrupt onset, severe disease 5 days after subcuta-
eous inoculation, leading to the death of greater than 80% of the
nimals. While intra-cerebral inoculation of suckling mice has been
reviously done for the purposes of recovering OROV from clinical
amples and propagation of virus stocks, and intraperitoneal infec-
ion has been done to test antiviral drugs (Livonesi et al., 2006,
007a,b; Rodrigues et al., 2011), to the best of our knowledge thisd E) brains of mock-infected animals; (B and F) brains of OROV-infected mice; (C)
tion: 400× in all ﬁgures.
is the ﬁrst pathogenesis study of a mouse experimental model of
OROV infection following subcutaneous inoculation.
The most prominent clinical features were inability to suckle,
apathy, paralysis, and rapid progression to death. OROV was recov-
ered in high titers from the brain, but not from other tissues of
the infected animals. Immunostaining also revealed heavy accu-
mulation of OROV nucleocapsid protein in NeuN-positive cells, but
not in other cells of the brain and spinal cord. This restriction
of OROV replication to neurons points out to the neurotropism
of this agent in this experimental model. OROV was  also found
to be strongly neurotropic for experimentally infected hamsters
(Rodrigues et al., 2011), but in that model signiﬁcant viral replica-
tion was  also present in liver and blood, in addition to brain. Such
lack of viral replication in other organs in the mouse model was
surprising, and is in sharp contrast with the systemic nature of
OROV infection in hamsters after inoculation by the same route
(Rodrigues et al., 2011). This difference between two  experimen-
tal rodent models of OROV infection highlights the importance of
host-dependent determinants of outcomes of infection by a viral
agent.
OROV was  recovered from the brain 4–5 days p.i., generally pre-
ceding the onset of obvious disease by one day. Symptoms were
frankly established only after viral progeny accumulated to high
titers, indicating a causal relationship between neuropathogenesis
and productive OROV infection of the CNS.
Despite the severity of the neural disease caused by OROV,
only mild inﬂammatory reaction was  observed in the CNS, starting
30 R.I. Santos et al. / Virus Research 170 (2012) 25– 33


















animals reveals abundant brown signal as compared to sections of mock-infected 
nimals is indicated by brown signal which is lacking in sections of mock-infec
agniﬁcations: 100× (A–D) and 400× (E–H).
n the 4th day p.i., and roughly coinciding with the detection of
iable virus in the brain by titration. Lymphomonocytic meningitis
as noted, along with microglial activation, conﬁrmed by an
ncrease in expression of Iba1, a protein expressed selectively in
ctivated microglia/macrophages (Postler et al., 2000). The limited
NS inﬂammation seen on the histopathology of the brain, along
ith the accumulation of OROV within neurons, causing profound
hysiologic damage in these cells, is reminiscent of rabies (Bleck
nd Rupprecht, 2002). As previously shown for other Bunyaviridae
Bridgen et al., 2001; Leonard et al., 2006; Weber et al., 2002), such
ittle inﬂammation could be due to the inhibition of inﬂammatory
eaction by a viral protein. However, another explanation would
e that the CNS invasion by OROV in this model does not occur by
upture of the blood–brain barrier, but instead by a neural route,
 ﬁnding consistent with strong neurotropism.ls (A and C); (E–H) Iba1 staining in brain (F) and spinal cord (H) of OROV-infected
imals (E and G). Arrows point to strongly Iba1-positive cells in the spinal cord.
Interestingly, even though neonatal mice are generally con-
sidered to be immunologically immature, OROV caused spleen
hyperplasia early after inoculation, even in the absence of OROV
recovery or antigen detection in the spleen. It is possible that upon
subcutaneous inoculation and prior to CNS invasion, OROV may
undergo early replication at the portal of entry in the skin, or
in adjacent lymphonodes, but reaching only limited levels, pos-
sibly below the threshold of OROV detection methods. If proven,
such early replication of OROV prior to CNS invasion could cause
systemic immune activation, which could explain the spleen hyper-
plasia. Later on, after infection of the CNS is established, there
would be activation of microglia and astrocytes. The presence of
hepatic giant cells was noted later in the course of infection, in
the absence of detectable OROV antigen or viral replication in the
liver. Hepatic tropism was a major feature of OROV in the hamster
R.I. Santos et al. / Virus Research 170 (2012) 25– 33 31
Fig. 5. Apoptosis detection in OROV infected brain. (A) TUNEL assay performed in frozen sections of control and OROV infected brain (3 and 6 days p.i.); (B and C) TUNEL
assay  and NeuN (B) or GFAP (C) immunoﬂuorescence. TUNEL is in red, NeuN or GFAP in green, and yellow/orange tones are colocalization (white arrows) on the 6th day p.i.
(For  interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of the article.)
Fig. 6. Multiple-step immunohistochemistry of an OROV infected brain section. Sucessive immunohistochemistry reactions were performed using anti-NeuN, anti-GFAP,
anti-Iba1 and anti-OROV antibodies. Black arrows indicate OROV infected neurons; black arrowheads indicate astrocytes; white arrowheads indicate Iba1-positive cells
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odel of infection, with pronounced liver damage, heavy stain-
ng for OROV antigen, and signiﬁcant OROV titres recovered from
iver homogenates (Rodrigues et al., 2011). These ﬁndings were
bsent in the mouse model. It is possible that, in mouse, liver
acrophage activation and giant cell formation resulted from some
ort of systemic immune activation, or from a paracrine action of a
roduct of the virus–cell interaction produced elsewhere, such as in
eurons.
Cells positive for Iba1 in the CNS were seen virtually always
n association with histological signs morphologically suggestive
f neuronal phagocytosis, such as the close presence of weakly
ositive neuronal remains. This feature suggests that neuronal
njury induced by OROV, with subsequent neuronal phagocyto-
is, could play a central role in the pathogenesis of infection in
he mouse model (Stolzing and Grune, 2004). Neuronal phago-
ytosis is a common feature of CNS viral infections, and is
requently involved in the clearance of virus-infected cells dam-
ged by necrosis or apoptosis (Messmer and Pfeilschifter, 2000;
tolzing and Grune, 2004). Since CNS inﬂammation was  so mild
n this model, neuronal phagocytosis is likely to be involved
n the clearance of OROV-infected apoptotic neurons. We  have
reviously shown that upon entry by acid dependent endocy-
osis, OROV causes apoptosis of infected cells of human origin
n vitro (Acrani et al., 2010; Santos et al., 2008), and a role for
poptosis in the pathogenesis of OROV human infection awaits
onﬁrmation.
There have been no published reports of OROV-related human
eaths or autopsies. Therefore, very little is known about the
athogenesis of OROV human infections. Based on published
linical descriptions of cases, OROV infections more frequently
ause systemic febrile illnesses, without prominent CNS damage
Pinheiro et al., 1976, 1981; Rosa et al., 1996). Therefore, while
n overtly neurotropic model of rodent experimental infection
s clearly different from what is seen in most cases of OROV
ever in humans, it should be kept in mind that OROV retains
he ability to invade the human CNS, with registered occurrence
f meningitis associated with recovery of OROV from the CSF,
s well as occasional cases of diplopia and nystagmus, possibly
elated to virus related neurologic damage (Pinheiro et al., 1982).
t is important to remember that mild or rare clinical manifes-
ations of human neural involvement and encephalitis may  have
one unnoticed amidst the impressively high numbers of cases
ecorded in descriptive epidemiology reports of OROV sweeping
utbreaks.
The development of experimental models is a necessity for
irologists to understand pathogenesis. An ideal viral experimen-
al model would be one that most closely resembled the human
isease, but this is hardly ever the case with most animal models
f human viral infections. Experimental infections of non-human
rimates, phylogenetically closer to humans, are very costly and
umbersome to carry out in rare primate research centers. This
eport describes a subcutaneous experimental infection of suck-
ing mouse with OROV, resulting in severe disease, with prominent
iral accumulation in neurons of brain and spinal cord, and associ-
ted with only mild inﬂammatory inﬁltrate, but causing extensive
lial activation. In addition to its potential use in preclinical testing
f prophylactic or therapeutic intervention for OROV, this model
hould become useful to study neuroinvasiveness and neuropatho-
enesis caused by an Orthobunyavirus.
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